Biohaven announced that Bruce Car will retire as Chief Scientific Officer and transition to part‑time Chief Innovation Officer, and David Pirman was promoted to Executive Vice President and Head of Discovery, effective July 13, 2026.
| IndividualBruce Car, Ph.D.David Pirman, Ph.D. | RoleChief Scientific Officer → Chief Innovation Officer (part‑time); remains executive officerExecutive Vice President and Head of Discovery | Type of ChangeRetired from CSO; transitioned to part‑time appointmentPromoted | Effective DateJuly 13, 2026July 13, 2026 | ReasonMutual agreement to retire as CSO and continue in new roleNot disclosed | Replacement InfoNot applicable (transitioned to new part‑time role)N/A | Background DetailsWill focus on advancing scientific initiatives and external collaborations, including leading assets under collaboration with Bexorg, Inc.Will lead internal drug‑discovery organization and oversee research programs | Board/Committee Role ChangesNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.